3D Global Biotech Inc. (TPEX:6808)
Taiwan · Delayed Price · Currency is TWD 31.30
-0.70 (-2.19%)
Sep 7, 2026, 1:25 PM CST
3D Global Biotech Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 30.34 | 17.45 | 56.12 | 21.82 | 15.53 | 20.37 |
Short-Term Investments | 453.78 | 459.8 | 647.74 | 144.2 | 192.9 | 212.8 |
Cash & Short-Term Investments | 497.11 | 477.25 | 703.86 | 166.02 | 208.43 | 233.17 |
Cash Growth | -35.47% | -32.20% | 323.97% | -20.35% | -10.61% | -15.74% |
Accounts Receivable | 16.92 | 71.98 | 119.58 | 1.35 | 1.09 | 1.23 |
Other Receivables | - | 1 | 2.99 | 0.59 | 0.44 | 0.41 |
Receivables | 16.92 | 72.98 | 122.57 | 1.94 | 1.53 | 1.64 |
Inventory | 18.67 | 22.38 | 7.04 | 3.6 | 3.37 | 0.88 |
Other Current Assets | 0.14 | 1.9 | 2.34 | 4.12 | 2.68 | 4.15 |
Total Current Assets | 551.05 | 574.51 | 835.81 | 175.67 | 216.01 | 239.85 |
Property, Plant & Equipment | 74.5 | 59.82 | 92.77 | 13.15 | 21.02 | 28.17 |
Long-Term Investments | 66.51 | 355.6 | - | - | - | - |
Other Intangible Assets | 66.1 | 73.17 | 87.79 | 102.29 | 117.09 | 152.3 |
Long-Term Deferred Tax Assets | 58.97 | 26.21 | 18.56 | 16.27 | 15.31 | 3.2 |
Other Long-Term Assets | 1.34 | 1.34 | 2.65 | 16.77 | 1.84 | 0.99 |
Total Assets | 818.48 | 1,091 | 1,038 | 324.15 | 371.26 | 424.52 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.74 | 2.77 | 16.08 | 3.33 | 2.22 | 0.67 |
Accrued Expenses | 19.06 | 13.02 | 14.34 | 7.69 | 7.61 | 6.35 |
Current Portion of Leases | 7.09 | 7.02 | 11 | 6.3 | 6.37 | 5.5 |
Current Unearned Revenue | 5.13 | 14.4 | 6.63 | 7.31 | 2.22 | - |
Other Current Liabilities | 13.2 | 3.59 | 4.41 | 1.87 | 1.74 | 2.44 |
Total Current Liabilities | 47.48 | 40.8 | 52.46 | 26.49 | 20.17 | 14.95 |
Long-Term Leases | 38.07 | 41.63 | 73.77 | 4.08 | 10.38 | 15.81 |
Long-Term Deferred Tax Liabilities | 0.2 | 23.69 | 6.65 | - | - | 3.94 |
Other Long-Term Liabilities | - | - | - | 0.11 | 0.11 | 0.11 |
Total Liabilities | 85.75 | 106.12 | 132.88 | 30.68 | 30.66 | 34.81 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 778.4 | 778.4 | 778.4 | 568.09 | 557.4 | 539.7 |
Additional Paid-In Capital | 39.25 | 37.76 | 34.59 | 1.22 | 2.08 | 1.8 |
Retained Earnings | 94.93 | 116.96 | 91.7 | -275.84 | -218.88 | -151.79 |
Treasury Stock | -43.02 | -43.02 | - | - | - | - |
Comprehensive Income & Other | -136.84 | 94.43 | - | - | - | - |
Shareholders' Equity | 732.73 | 984.53 | 904.69 | 293.47 | 340.6 | 389.71 |
Total Liabilities & Equity | 818.48 | 1,091 | 1,038 | 324.15 | 371.26 | 424.52 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 45.16 | 48.66 | 84.76 | 10.38 | 16.75 | 21.31 |
Net Cash (Debt) | 451.95 | 428.59 | 619.1 | 155.64 | 191.68 | 211.87 |
Net Cash Growth | -33.91% | -30.77% | 297.78% | -18.80% | -9.53% | -17.22% |
Net Cash Per Share | 5.79 | 5.41 | 8.75 | 2.77 | 3.49 | 3.93 |
Filing Date Shares Outstanding | 76.98 | 76.98 | 77.84 | 56.81 | 55.74 | 53.97 |
Total Common Shares Outstanding | 76.98 | 76.98 | 77.84 | 56.81 | 55.74 | 53.97 |
Working Capital | 503.57 | 533.71 | 783.35 | 149.17 | 195.84 | 224.9 |
Book Value Per Share | 9.52 | 12.79 | 11.62 | 5.17 | 6.11 | 7.22 |
Tangible Book Value | 666.63 | 911.36 | 816.91 | 191.18 | 223.52 | 237.41 |
Tangible Book Value Per Share | 8.66 | 11.84 | 10.49 | 3.37 | 4.01 | 4.40 |
Machinery | 28.06 | 25.29 | 20.25 | 14.61 | 14.38 | 13.77 |
Construction In Progress | 16.67 | - | - | - | - | - |
Leasehold Improvements | 13.25 | 13.25 | 13.15 | 12.57 | 12.57 | 12.57 |